Tag Archives: Viread

An international study on a temporary HIV prevention pill is underway. The concept is known as pre-exposure prophylaxis or PrEP. In a massive medical trial on three continents, doctors are testing a controversial pill that could temporarily boost immunity against HIV before a person is even exposed to the virus. If the pill works safely, doctors must then address whether …

It’s a complicated turn of events for Gilead, the maker of HIV drug Viread. The 9th Circuit Court has reinstated a securities class action suit against the drug maker which claims that Gilead had misled investors about the demand for Viread. The suit charges that Gilead fostered demand for Viread by using improper marketing such as “aggressively promoting off-label uses.” …